2005
DOI: 10.1128/mcb.25.18.8251-8258.2005
|View full text |Cite
|
Sign up to set email alerts
|

Cell Cycle-Regulated Inactivation of Endothelial NO Synthase through NOSIP-Dependent Targeting to the Cytoskeleton

Abstract: Nitric oxide (NO) plays a key role in vascular function, cell proliferation, and apoptosis. Proper subcellular localization of endothelial NO synthase (eNOS) is crucial for its activity; however, the role of eNOS trafficking for NO biosynthesis remains to be defined. Overexpression of NOS-interacting protein (NOSIP) induces translocation of eNOS from the plasma membrane to intracellular compartments, thereby impairing NO production. Here we report that endogenous NOSIP reduces the enzymatic capacity of eNOS, s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
64
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 38 publications
(71 citation statements)
references
References 42 publications
7
64
0
Order By: Relevance
“…50,51 In platelets, Hsp90 has been shown to associate with NOS3 and to enhance its activity in response to insulin 31 and after binding to the globular form of ␤-actin. 26 In endothelial cells, NOSIP and NOSTRIN both inhibit, 52,53 and dynamin-2 and porin both augment, 54,55 NOS3 activity. However, at present nothing is known about the possible regulation of NOS3 in platelets by these proteins.…”
Section: The L-arginine-no Pathway In Plateletsmentioning
confidence: 99%
“…50,51 In platelets, Hsp90 has been shown to associate with NOS3 and to enhance its activity in response to insulin 31 and after binding to the globular form of ␤-actin. 26 In endothelial cells, NOSIP and NOSTRIN both inhibit, 52,53 and dynamin-2 and porin both augment, 54,55 NOS3 activity. However, at present nothing is known about the possible regulation of NOS3 in platelets by these proteins.…”
Section: The L-arginine-no Pathway In Plateletsmentioning
confidence: 99%
“…Recently, we described two novel eNOSinteracting proteins termed NOSIP (eNOS interacting protein) and NOSTRIN (eNOS trafficking inducer), both of which influence localization of eNOS. For NOSIP, targeting of eNOS to the cytoskeleton appears to be one of the protein's major functions (Schleicher et al, 2005). Interaction of eNOS with NOSTRIN, by contrast, leads to translocation of eNOS from the plasma membrane to intracellular vesicular structures, most likely through an endocytic process (Zimmermann et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…In support of this model, we described two novel eNOS-interacting proteins termed NOSIP (for eNOS-interacting protein) and NOSTRIN (for eNOS-trafficking inducer), which both influence localization of eNOS. For NOSIP, targeting of eNOS to the cytoskeleton seems to be one of the protein's major functions (Schleicher et al, 2005). Overexpression of NOSTRIN, in contrast, leads to translocation of eNOS from the PM to intracellular vesicular structures (Zimmermann et al, 2002), possibly involving an endocytic process (Icking et al, 2005).…”
mentioning
confidence: 99%